Event Overview

While genomics and transcriptomics reveal what genes are present and active in cells, they provide limited information on a cell’s actual function. To fill in this large information gap, researchers turn to sophisticated single-cell transcriptomic and proteomic techniques and resources to connect a cell’s instructions to its behavior. With these tools, researchers gain knowledge in a range of research areas, including precision medicine, systems biology, cancer, neuroscience, and immunity.

In this virtual summit brought to you by IsoPlexis, an expert panel will discuss how a functional proteomics library and a novel technology that links transcriptomic and functional proteomics data within and across single cells usher in a new era of biological research. These tools help researchers understand cellular heterogeneity and predict cell responses. Additionally, the panel will highlight how these technologies help researchers identify and study single-cell subsets of highly functional "superhero" cells, which are critical to driving long-term responses in cell and immune therapies via functional proteins.

An expert panel will discuss
  • Combining transcriptomics and functional proteomics data within individual single cells and across many cells in parallel with the new DuomicTM chip technology
  • Using Duomic to identify the genetic drivers of aberrant malignancies in solid tumors
  • Uncovering the genetic drivers of supercharged, highly functional CAR T cells
  • How the Functional Cell Library confirms critical functional insights learned from the cell atlas

  • Friday, December 10, 2021
    1:00 - 4:00 PM Eastern Time


    TS_Webinar_Symposium_Integrating Single-Cell Transcriptomics and Proteomics: A New Era of Biological Research December 10, 2021

    You must have Javascript and Cookies enabled to access this webcast.

    Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.

    Sponsored by